Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
16,7 ILa | -0,60% | 0,00% | -56,28% |
Vakgebied
Aantal werknemers: 79
Verkoop per activiteit
ILS in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
License
96,0
%
| - | - | 17 | 96,0 % | - |
Oncology and Hematology
4,0
%
| 0 | nan % | 1 | 4,0 % | - |
Verkoop per regio
ILS in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 0 | nan % | 18 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Philip Serlin
CEO | Chief Executive Officer | 62 | 24-05-09 |
Mali Zeevi
DFI | Director of Finance/CFO | 48 | 01-01-09 |
Irit Gliko-Kabir
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-17 |
John Lacey
IRC | Investor Relations Contact | - | - |
Asaf Aloni
PRN | Corporate Officer/Principal | - | - |
Tali Yaron Dalah
AUD | Comptroller/Controller/Auditor | 46 | - |
Ella Sorani
PRN | Corporate Officer/Principal | 56 | 01-02-17 |
Holly May
PRN | Corporate Officer/Principal | - | 16-06-22 |
Corporate Officer/Principal | - | 01-08-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sandra Panem
BRD | Director/Board Member | 77 | 24-02-14 |
Avraham Molcho
BRD | Director/Board Member | 66 | 01-01-10 |
Aharon Schwartz
CHM | Chairman | 80 | 01-01-04 |
Director/Board Member | 65 | 19-08-13 | |
Raf Hofstein
BRD | Director/Board Member | 74 | 01-01-03 |
Rami Dar
BRD | Director/Board Member | 67 | 01-07-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 199 089 165 | 1 194 817 450 ( 99,64 %) | 0 | 99,64 % |
Bedrijfsgegevens
BioLineRx Ltd.
Modi'in Technology Park 2 HaMa'ayan Street
7177871, Modi'in
+972 8 642 9100
http://www.biolinerx.comSector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-56,28% | 52,51 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers BLRX
- Onderneming BioLineRx Ltd.